Kimberly-Clark Advances $48.7 Billion Kenvue Acquisition with $7 Billion Debt Exchange

Key numbers

Deal value	$7.0B
Share of market cap	21.3%
Share of annual revenue	42.6%

Key highlights

• Secured requisite consents to amend Kenvue indentures for $7.0 billion in outstanding senior notes
• Exchange consideration features $970 in new Kimberly-Clark notes per $1,000 of Kenvue principal
• Early participation incentives include a $30 note premium and a $1.00 cash payment per unit
• Indentures amended to eliminate SEC reporting covenants and restrictive merger constraints for Kenvue
• Acquisition closing and debt settlement are anticipated to occur in late 2026

What Is the Deal?

Kimberly-Clark Corporation is executing a massive $48.7 billion acquisition of Kenvue Inc., formerly the consumer health division of Johnson & Johnson. As a primary component of the transaction's financing and integration, the company launched offers to exchange up to $7.0 billion in Kenvue senior notes for newly issued Kimberly-Clark debt. On October 13, 2026, the company confirmed that a sufficient number of noteholders participated in the early tender phase to adopt proposed amendments to the Kenvue indenture. These amendments will eliminate most restrictive covenants and reporting obligations, effectively aligning Kenvue's capital structure with Kimberly-Clark's corporate framework upon the deal's closing.

Deal Structure & Terms

• Eligible holders receive $970 in new Kimberly-Clark notes for every $1,000 of Kenvue principal tendered.
• An early participation premium provides an additional $30 in principal amount of new Kimberly-Clark notes.
• A cash payment of $1.00 per $1,000 principal was granted to holders participating by the October 9 deadline.
• The supplemental indenture eliminates the Securities and Exchange Commission reporting covenant for Kenvue series.
• Restrictions on Kenvue's ability to consolidate, merge, or transfer major assets have been removed.
• The exchange offers are scheduled to expire at 5:00 p.m. New York City time on October 27, 2026.

Strategic Rationale

The acquisition of Kenvue represents a transformative shift for Kimberly-Clark, significantly expanding its presence in the global health and wellness market. By absorbing Kenvue, Kimberly-Clark gains control over a premier portfolio of consumer brands, including Tylenol, Neutrogena, and Listerine. This move complements the company's established leadership in the personal care and tissue categories, currently anchored by brands such as Huggies and Kleenex. Management intends to leverage its extensive global distribution network to drive scale and operational efficiencies for Kenvue products, targeting high-growth opportunities in international retail markets where consumer defensive demand remains resilient.

Business & Financial Context

Kimberly-Clark currently holds a market capitalization of approximately $32.85 billion, making the $48.7 billion Kenvue acquisition a transaction of substantial magnitude relative to its size. The company recently reported annual revenues of $16.45 billion and is operating with a P/E ratio of 19.5x. Ahead of the merger, Kimberly-Clark has been streamlining its portfolio, notably through a $1.7 billion divestiture of its International Family Care and Professional business via a joint venture with Suzano S.A. For fiscal year 2026, the company has updated its guidance to reflect mid-single-digit growth in adjusted operating profit on a constant-currency basis.

Down 0.5% since our story on 13 Oct: $98.77 when we broke it → $98.29 at the close on 13 Oct. Daily closing prices. Source: Yahoo Finance.

Show the prices

14 Sep	$99.09
15 Sep	$98.68
16 Sep	$98.10
17 Sep	$98.19
18 Sep	$97.86
21 Sep	$97.74
22 Sep	$98.91
23 Sep	$97.70
24 Sep	$97.22
25 Sep	$98.43
28 Sep	$98.77
29 Sep	$98.99
30 Sep	$97.43
1 Oct	$94.34
2 Oct	$94.36
5 Oct	$95.41
6 Oct	$96.77
7 Oct	$96.48
8 Oct	$97.74
9 Oct	$97.59
12 Oct	$98.77
13 Oct	$98.29

KIMBERLY CLARK CORP · financial snapshot

Share price	$98.77
Market cap	$32.8B
Revenue (annual)	$16.4B
P/E (TTM)	19.5×
1-month price change	+0.29%
Sector	Consumer DefensiveHousehold & Personal Products

Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.